中國核電(601985.SH)擬以5億元增資中國鈾業 持股比例4.23%
格隆匯12月11日丨中國核電(601985.SH)公佈,公司擬以現金5億元增資公司控股股東的全資子公司中國鈾業有限公司(以下簡稱“中國鈾業”),增資後約持有中國鈾業4.23%股權(以國資委最終備案數據為準)。
中國鈾業作為中核集團的天然鈾專營供應商,與公司業務關聯緊密。公司增資中國鈾業後,可以進一步強化與之的聯繫,有助於加強核電站天然鈾供給和保障,實現協同發展並利益共享,逐步發展成為更緊密的戰略同盟關係,打造核能產業生態鏈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.